Alexandra Hospital develops world’s novel A.I. algorithm (with international patent) that enhances accuracy and efficiency of robotic total knee replacement
Newspoints: An A.I. algorithm for robotic total knee replacement (rTKR) has secured an international Patent Cooperation Treaty (PCT) patent, that protects this algorithm for robotic total knee replacement for its uniqueness, exclusivity, novelty and proprietary rights. Filed since August 2024 in over 150 member countries to seek patent protection, to-date, there...
Forescout Recognized by Frost & Sullivan with the 2025 Global Product Leadership Award for Enabling Single Platform Approach to Medical Device Security
Forescout's Platform offers comprehensive, real-time visibility across organizational network architecture, and boosts the operational efficiency and overall productivity of under resourced healthcare security teams. SAN ANTONIO, Feb. 11, 2025 /PRNewswire/ -- Recently Frost & Sullivan assessed the medical device security industry, and based on its findings, recognizes Forescout with the 2025 Global Product Leadership Award. The company has over 20 years...
Cathay Biotech to showcase thermoplastic bio-based composite materials (bio-PPA CFRT) at 2025 JEC World
PARIS, Feb. 11, 2025 /PRNewswire/ -- The global composite materials industry's attention will soon be focused on the JEC World 2025 exhibition, which will be held from March 4th to 6th at the Paris Nord Villepinte Exhibition Centre in France. At this highly anticipated event, Cathay Biotech will showcase its breakthrough application achievements and solutions of thermoplastic bio-based composite materials...
111, Inc. Regains Compliance with NASDAQ Requirement
SHANGHAI, Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that...
Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET™ Scanner
WINNIPEG, MB, Feb. 11, 2025 /PRNewswire/ -- Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and compatibility testing of the Cubresa BrainPET™ scanner in Siemens Healthineers MAGNETOM MRI scanners of all field strengths. Cubresa_Inc_Cubresa_and_Siemens_Healthineers_Sign_Global_Master "Cubresa is proud...
ZIWIG ENDOTEST®: FAST-TRACK REIMBURSEMENT FOR 25 000 PATIENTS FOR FIRST SALIVA TEST TO DIAGNOSE ENDOMETRIOSIS IN 80 MEDICAL CENTERS IN FRANCE
LYON, France, Feb. 11, 2025 /PRNewswire/ -- Ziwig, a French biotech company committed to advancing women's health, announces the fast-track reimbursement of Ziwig Endotest® - the first saliva diagnostic test for endometriosis- for 25 000 patients across 80 medical centers in France thanks to the Innovation Funding Feb 11 decree. Ziwig...
Sustainable Leather Technology Advances With Collaboration Between Meatable and Pelagen
LEIDEN, Netherlands, Feb. 11, 2025 /PRNewswire/ -- Meatable, a leader in cultivated meat technology, has started a collaboration effort with Pelagen, a pioneering company focused on developing animal-free leather. This collaboration enables Pelagen to explore the use of the award-winning opti-ox™ technology to enhance its production of skin tissue from animal cells,...
Infinitus Secures Approval for National-Level Joint Laboratory Project, Ushering in a New Chapter of China-Europe Scientific Research Collaboration
GUANGZHOU, China, Feb. 10, 2025 /PRNewswire/ – In a significant announcement at the recent Infinitus Global Annual Meeting, Infinitus (China) Company Ltd. secured approval for its Sino-British Joint Laboratory on Health and Aging project. This initiative is part of the intergovernmental international science and technology cooperation under China's National Key R&D Program. The approval marks a crucial advancement...
Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China
LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the latest step in Bio X Cell's growing international...
GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025
YONGIN, South Korea , Feb. 11, 2025 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held from Feb. 3rd to 7th, 2025, in San Diego, USA. WORLD Symposium 2025 is an international...
